February 22, 2011
Sunnyvale, CA - Dionex, the leader in monoclonal antibody (MAb) analysis solutions, is pleased to announce the release of three new MAbPac™ SCX-10 column formats for faster MAb analysis, pH gradients, and LC/MS use. The MAbPac SCX-10 is designed specifically for high-resolution analysis and characterization of MAb variants. The new formats include: 4 × 150 [...]
Quanterix Announces New Technology Evaluation Agreement
February 22, 2011
CAMBRIDGE, MA - Quanterix Corporation, enabling a new generation of diagnostic tests based on revolutionary Single Molecule Array (SiMoA™) technology, today announced that it has entered into an evaluation agreement with Novartis Diagnostics on the potential use of Quanterix’s SiMoA platform technology for diagnostic use. The evaluation will be conducted at Quanterix and will focus [...]
Waters Corporation Announces Stock Repurchase Program
February 22, 2011
MILFORD, Mass. - Waters Corporation (NYSE:WAT) announced today that on February 16, 2011, its Board of Directors authorized the Company to repurchase up to $500 million of its outstanding common shares over the next 24 months. The previous $500 million share repurchase program authorized in February 2009 was recently completed. Purchases will be made through [...]
Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe
February 22, 2011
CARLSBAD, Calif. - Life Technologies Corporation (Nasdaq: LIFE), today announced Dr. Angel Carracedo and Dr. Mark Pallen as the winners of the European Ion Torrent Personal Genome Machine (PGM™) Sequencer Grants Program. Each scientist will receive an Ion PGM and because of the ubiquitous nature of the Ion Torrent sequencing technology, these scientists will be [...]
February 22, 2011
PLEASANTON, Calif. and HOPKINTON, Mass - IntegenX Inc. (a privately held corporation) and Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced a license agreement providing IntegenX access to Caliper’s microfluidics patent portfolio. IntegenX will leverage its proprietary MOVe™ microvalve technology and Caliper’s microfluidic intellectual patent estate to accelerate commercialization of its Apollo 200 RapidHIT™ DNA [...]
Stereotaxis Announces Election of Joseph D. Keegan to Board of Directors
February 22, 2011
ST. LOUIS - Stereotaxis, Inc. (Nasdaq: STXS) today announced that Joseph D. Keegan, Ph.D., 55, was elected to its Board of Directors. Mr. Keegan is President and CEO of ForteBIO, Inc., a life science analytical instrument company. Dr. Keegan has more than 25 years of experience managing high growth life science businesses. Under Dr. Keegan's [...]
February 22, 2011
ROCKVILLE, Md. - Macrogen, Inc (Seoul, Korea) announces the formation of Axeq Technologies, a US-based division with operations and offices in the US, Europe and Asia. “Axeq” is a premium brand representing a whole new experience and industry-leading standards in DNA sequencing service. Axeq Technologies is dedicated to providing premier next-generation sequencing services and support [...]
Renishaw Diagnostics Enables Customised Multiplex Assays for Precious Research Samples
February 22, 2011
Glasgow, Scotland - Renishaw Diagnostics Ltd, a world leading provider of trace level detection technologies based on the exploitation of surface enhanced Raman scattering (SERS) and surface enhanced resonance Raman scattering (SERRS), for research and molecular diagnostics applications, today announced the launch of its first research use only (RUO) multiplex assay system which allows precious [...]
GenoLogics Launches Rapid Scripting™ API for Next-Generation Genomics Labs
February 22, 2011
VICTORIA, British Columbia - GenoLogics, a leading provider of laboratory information management system (LIMS) software specifically designed for next-generation genomics labs, today announced the availability of GenoLogics Rapid Scripting™ Application Programming Interface (API) for scientific programmers and bioinformaticians. The GenoLogics Rapid Scripting™ API provides control and flexibility so scientific programmers can quickly and easily automate [...]
NanoString Technologies Introduces Multiplexed Assay Kit for Human Molecular Karyotyping
February 22, 2011
SEATTLE, Wash. - NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the first fixed-panel assay product to be developed on its Copy Number Variation (CNV) detection platform – the nCounter® Human Karyotype Panel. Researchers can use [...]

